Abstract 6852: Monogenic and Polygenic Risk Enrichment in Thoracic Aortic Aneurysm and Dissection Across Ancestries
Abstract
Background: Thoracic aortic aneurysm and dissection (TAAD) is a devastating condition with high heritability and substantial morbidity and mortality. Current ACC/AHA guidelines recommend surveillance imaging for first-degree relatives of affected individuals, who carry 4 to 5-fold greater risk of TAAD. However, most TAAD patients lack a known affected relative and clinical genetic evaluation - relying predominantly on monogenic testing - identifies pathogenic variants in only a small fraction of cases. Whether polygenic susceptibility, which has emerged as a determinant of TAAD risk, could broaden the screening framework remains undefined. Methods: Among 414,830 participants of the All of Us Research Program with whole genome sequencing (WGS), TAAD cases were identified and matched 1:4 to controls by age and sex. Pathogenic or likely pathogenic (P/LP) variants in 17 high-confidence aortopathy genes were identified from ClinVar-annotated WGS. An 89-variant ascending aortic diameter polygenic risk score (PRS; PGS Catalogue #PGS002267) was applied to all participants. Firth’s bias-reduced and standard logistic regression models were used to estimate the associations of P/LP carrier status and PRS with TAAD, respectively, adjusting for age, sex, and five genetic principal components and stratifying by genomically inferred ancestry (European [EUR] and African [AFR]). Results: A total of 3,083 participants with TAAD and 12,332 matched controls were identified. P/LP variants in aortopathy genes were identified in 0.88% of EUR cases versus 0.07% of EUR controls (OR: 11.08; 95% CI: 4.88-28.98; p<0.001), with FBN1 most commonly implicated. Among AFR participants, P/LP carrier prevalence was comparable among cases (0.84%) and the association with TAAD was significant (OR: 6.61; 95% CI: 1.27-40.19; p=0.026) (Figure 1). The aortic diameter PRS demonstrated a monotonic dose-response with TAAD in EUR participants (OR per SD increase: 1.47; 95% CI: 1.40-1.54; p<0.001), with individuals in the top PRS decile carrying 4-fold greater odds than those in the lowest decile (OR: 4.31; 95% CI: 3.41-5.44; p<0.001). The PRS was also associated with TAAD among AFR participants, with attenuated effects relative to EUR participants (OR per-SD: 1.24; p<0.001; top vs bottom decile OR: 2.54; p<0.001) (Figure 2). Conclusion: P/LP variants in established aortopathy genes conferred markedly elevated individual risk of TAAD but were present in fewer than 1% of cases. A PRS identified a substantially larger at-risk population, with risk estimates approaching the magnitude used to justify current family-based surveillance recommendations, potentially enabling proactive risk identification before a sentinel familial event. These findings motivate continued genetic discovery and the development of multi-ancestry PRS to support equitable implementation of genetic risk stratification for aortic disease.